CytoDyn Inc. of VANCOUVER, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-22. $1.9M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 101 people.
| Name | Role | Location |
|---|---|---|
| Antonio G Migliarese | Executive Officer | Vancouver, WA |
| Michael A Klump | Director | Atlanta, GA |
| Richard G Pestell | Director | Wynnewood, PA |
| Richard G Pestell | Executive Officer | Wynnewood, PA |
| Ryan G Dunlap | Director | Vancouver, WA |
| Arvin Cyrus Arman | Executive Officer | Vancouver, WA |
| Karen J Brunke | Director | Vancouver, WA |
| Antonio Durkee Migliarese | Executive Officer | Vancouver, WA |
| Lishomwa C Ndhlovu | Director | Vancouver, WA |
| Tanya Durkee Urbach | Director | Vancouver, WA |
| Nitya G Ray | Executive Officer | Vancouver, WA |
| Christopher G Recknor | Executive Officer | Vancouver, WA |
| Harish Z Seethamraju | Director | Vancouver, WA |
| Scott A Kelly, M.D. | Director | Vancouver, WA |
| Scott A Kelly, M.D. | Executive Officer | Vancouver, WA |
| Nitya G Ray, Ph.D. | Executive Officer | Vancouver, WA |
| Nader Z Pourhassan, Ph.D. | Director | Vancouver, WA |
| Nader Z Pourhassan, Ph.D. | Executive Officer | Vancouver, WA |
| Samir R Patel, M.D. | Director | Vancouver, WA |
| Christopher G Recknor, M.D. | Executive Officer | Vancouver, WA |
| Antonio G Migliarese, C.P.A. | Executive Officer | Vancouver, WA |
| Michael D Mulholland | Executive Officer | Vancouver, WA |
| Mahboob G Rahman, M.D., Ph.D. | Executive Officer | Vancouver, WA |
| Arian G Colachis | Executive Officer | Vancouver, WA |
| Scott Kelly, M.D. | Director | Vancouver, WA |
Showing 15 of 31 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-05-11 | D | $18.6M | $18.6M |
| 2022-09-19 | D/A | $21.8M | $21.8M |
| 2022-04-25 | D/A | — | $1.9M |
| 2021-12-03 | D | $53.6M | $11.4M |
| 2021-09-16 | D | $25.2M | $2.9M |
| 2020-12-16 | D | $1.2M | — |
| 2020-12-16 | D | $1.0M | $1.0M |
| 2020-04-07 | D/A | $11.4M | $7.6M |
| 2020-03-30 | D | $1.2M | $882K |
| 2020-02-14 | D | $7.6M | $7.6M |
| 2019-11-12 | D/A | $20.0M | $7.8M |
| 2019-04-02 | D | $5.0M | $3.2M |
| 2018-09-10 | D | $25.0M | $13.2M |
| 2018-02-28 | D/A | $17.6M | $17.6M |
| 2017-11-16 | D | $15.0M | $1.2M |